Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome

N. S. Melberg; M. A. Thomas; J. D. Dickinson; S. Valluri; P. A. Campochiaro

doi:10.1016/S0161-6420(96)30566-6

Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome

N. S. Melberg, M. A. Thomas, J. D. Dickinson, S. Valluri, P. A. Campochiaro

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose: To report the authors' experience with recurrent neovascularization after subfoveal surgery in the presumed ocular histoplasmosis syndrome (POHS). Methods: One-hundred seventeen patients with POHS and subfoveal choroidal neovascularization were followed a median of 13 months after submacular surgery. Results: Recurrent neovascularization developed in 51 eyes (44%). The median time to recurrence was 3 months (range, 0.5-28 months). Recurrence location was extrafoveal in 16%, juxtafoveal in 18%, and subfoveal in 66%. Sixteen eyes were treated with laser photocoagulation, 17 eyes underwent repeat submacular surgery, and 18 eyes were observed. The visual outcome for patients with recurrences amenable to laser was better than that for patients who were observed or who underwent surgery. Conclusion: Recurrent neovascularization after surgery is common; prompt recognition may allow laser photocoagulation.

Original language	English (US)
Pages (from-to)	1064-1068
Number of pages	5
Journal	Ophthalmology
Volume	103
Issue number	7
DOIs	https://doi.org/10.1016/S0161-6420(96)30566-6
State	Published - Jan 1 1996
Externally published	Yes

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/S0161-6420(96)30566-6

Cite this

@article{e87146b7d6c947799fd6e0c75409e0c4,

title = "Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome",

abstract = "Purpose: To report the authors' experience with recurrent neovascularization after subfoveal surgery in the presumed ocular histoplasmosis syndrome (POHS). Methods: One-hundred seventeen patients with POHS and subfoveal choroidal neovascularization were followed a median of 13 months after submacular surgery. Results: Recurrent neovascularization developed in 51 eyes (44%). The median time to recurrence was 3 months (range, 0.5-28 months). Recurrence location was extrafoveal in 16%, juxtafoveal in 18%, and subfoveal in 66%. Sixteen eyes were treated with laser photocoagulation, 17 eyes underwent repeat submacular surgery, and 18 eyes were observed. The visual outcome for patients with recurrences amenable to laser was better than that for patients who were observed or who underwent surgery. Conclusion: Recurrent neovascularization after surgery is common; prompt recognition may allow laser photocoagulation.",

author = "Melberg, {N. S.} and Thomas, {M. A.} and Dickinson, {J. D.} and S. Valluri and Campochiaro, {P. A.}",

year = "1996",

month = jan,

day = "1",

doi = "10.1016/S0161-6420(96)30566-6",

language = "English (US)",

volume = "103",

pages = "1064--1068",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome

AU - Melberg, N. S.

AU - Thomas, M. A.

AU - Dickinson, J. D.

AU - Valluri, S.

AU - Campochiaro, P. A.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Purpose: To report the authors' experience with recurrent neovascularization after subfoveal surgery in the presumed ocular histoplasmosis syndrome (POHS). Methods: One-hundred seventeen patients with POHS and subfoveal choroidal neovascularization were followed a median of 13 months after submacular surgery. Results: Recurrent neovascularization developed in 51 eyes (44%). The median time to recurrence was 3 months (range, 0.5-28 months). Recurrence location was extrafoveal in 16%, juxtafoveal in 18%, and subfoveal in 66%. Sixteen eyes were treated with laser photocoagulation, 17 eyes underwent repeat submacular surgery, and 18 eyes were observed. The visual outcome for patients with recurrences amenable to laser was better than that for patients who were observed or who underwent surgery. Conclusion: Recurrent neovascularization after surgery is common; prompt recognition may allow laser photocoagulation.

AB - Purpose: To report the authors' experience with recurrent neovascularization after subfoveal surgery in the presumed ocular histoplasmosis syndrome (POHS). Methods: One-hundred seventeen patients with POHS and subfoveal choroidal neovascularization were followed a median of 13 months after submacular surgery. Results: Recurrent neovascularization developed in 51 eyes (44%). The median time to recurrence was 3 months (range, 0.5-28 months). Recurrence location was extrafoveal in 16%, juxtafoveal in 18%, and subfoveal in 66%. Sixteen eyes were treated with laser photocoagulation, 17 eyes underwent repeat submacular surgery, and 18 eyes were observed. The visual outcome for patients with recurrences amenable to laser was better than that for patients who were observed or who underwent surgery. Conclusion: Recurrent neovascularization after surgery is common; prompt recognition may allow laser photocoagulation.

UR - http://www.scopus.com/inward/record.url?scp=0029893563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029893563&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(96)30566-6

DO - 10.1016/S0161-6420(96)30566-6

M3 - Article

C2 - 8684795

AN - SCOPUS:0029893563

VL - 103

SP - 1064

EP - 1068

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 7

ER -

Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this